Eric J. Niesor
Nyon, VD, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Dalcetrapib decreases red blood cell sickling propensity in sickle cell disease.
Journal: Clinical hemorheology and microcirculation
Published: August 12, 2026
Impact of elevated red blood cell membrane cholesterol in sickle cell anemia patients: Effects of BRN-002, a 2-hydroxypropyl-β-cyclodextrin derivate, on red blood cell lipids, deformability, sickling and hemolysis.
Journal: Blood cells, molecules & diseases
Published: May 22, 2025
Effect of dalcetrapib, voxelotor and their combination on red blood cell deformability and sickling in sickle cell disease.
Journal: Clinical hemorheology and microcirculation
Published: April 21, 2025
Plasma monomeric ApoA1 and high-density lipoprotein bound ApoA1 are markedly decreased and associated with low levels of lipophilic antioxidants in sickle cell disease: A potential new pathway for therapy.
Journal: European journal of haematology
Published: March 12, 2024
HDL as Bidirectional Lipid Vectors: Time for New Paradigms.
Journal: Biomedicines
Published: April 19, 2022
Dalcetrapib and anacetrapib increase apolipoprotein E-containing HDL in rabbits and humans.
Journal: Journal of lipid research
Published: February 28, 2022
Role of Adenylate Cyclase 9 in the Pharmacogenomic Response to Dalcetrapib: Clinical Paradigm and Molecular Mechanisms in Precision Cardiovascular Medicine.
Journal: Circulation. Genomic and precision medicine
Published: April 02, 2021
HDL and atherosclerotic cardiovascular disease: genetic insights into complex biology.
Journal: Nature reviews. Cardiology
Published: August 11, 2017
Dalcetrapib and anacetrapib differently impact HDL structure and function in rabbits and monkeys.
Journal: Journal of lipid research
Published: May 04, 2017
Treatment With Dalcetrapib Modifies the Relationship Between High-Density Lipoprotein Cholesterol and C-Reactive Protein.
Journal: Journal of the American College of Cardiology
Published: March 10, 2016
Adenylyl Cyclase 9 Polymorphisms Reveal Potential Link to HDL Function and Cardiovascular Events in Multiple Pathologies: Potential Implications in Sickle Cell Disease.
Journal: Cardiovascular drugs and therapy
Published: December 02, 2015
Last Updated: 09/26/2026